Author Gross, Oliver
-
2006 | Journal Article
Bone marrow transplantation rescues Alport mice
Floege, J.; Kunter, U.; Weber, M. & Gross, O. (2006)
Nephrology Dialysis Transplantation, 21(10) pp. 2721-2723. DOI: https://doi.org/10.1093/ndt/gfl367
Details DOI PMID PMC WoS
-
2007 | Conference Abstract
Living donor kidney transplanation from relatives with mild urinary abnormalities in Alport syndrome: Risk, benefit and outcome in five families
Reinhardt, J.; Weber, M.; Mueller, G. A. & Gross, O. (2007)
Transplant International, 20
Oxford: Blackwell Publishing.
Details WoS
-
2007 | Journal Article
Nephroprotective effect of the HMG-CoA-reductase inhibitor cerivastatin in a mouse model of progressive renal fibrosis in Alport syndrome
Koepke, M.-L.; Weber, M.; Schulze-Lohoff, E.; Beirowski, B.; Segerer, S. & Gross, O. (2007)
Nephrology Dialysis Transplantation, 22(4) pp. 1062-1069. DOI: https://doi.org/10.1093/ndt/gfl810
Details DOI PMID PMC WoS
-
2008 | Journal Article |
Inner ear defects and hearing loss in mice lacking the collagen receptor DDR1
zum Gottesberge, A. M. M.; Gross, O.; Becker-Lendzian, U.; Massing, T. & Vogel, W. F. (2008)
Laboratory Investigation, 88(1) pp. 27-37. DOI: https://doi.org/10.1038/labinvest.3700692
Details DOI WoS
-
2008 | Journal Article
Understanding renal disorders as systemic diseases: the fascinating world of basement membranes beyond the glomerulus
Gross, O. (2008)
Nephrology Dialysis Transplantation, 23(6) pp. 1823-1825. DOI: https://doi.org/10.1093/ndt/gfn129
Details DOI PMID PMC WoS
-
2009 | Journal Article
Treatment of Alport syndrome: beyond animal models
Gross, O. & Kashtan, C. E. (2009)
Kidney International, 76(6) pp. 599-603. DOI: https://doi.org/10.1038/ki.2009.223
Details DOI
-
2009 | Conference Abstract
Mycophenolate Mofetil improves Kidney Function but not Survival in a COL4A3-deficient Mouse Model for Progressive Renal Fibrosis
Brandhorst, G.; Brehmer, F.; Petrova, D. T.; Gross, O.; Armstrong, V. W. & Oellerich, M. (2009)
Therapeutic Drug Monitoring, 31(5) 11th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, Montreal, CANADA.
Philadelphia: Lippincott Williams & Wilkins.
Details WoS
-
2009 | Journal Article
Stem cell therapy for Alport syndrome: the hope beyond the hype
Gross, O.; Borza, D.-B.; Anders, H.-J.; Licht, C.; Weber, M.; Segerer, S. & Torra, R. et al. (2009)
Nephrology Dialysis Transplantation, 24(3) pp. 731-734. DOI: https://doi.org/10.1093/ndt/gfn722
Details DOI PMID PMC WoS
-
2010 | Journal Article |
Integrin a2-deficient mice provide insights into specific functions of collagen receptors in the kidney
Girgert, R.; Martin, M.; Kruegel, J.; Miosge, N.; Temme, J.; Eckes, B. & Müller, G.-A. et al. (2010)
Fibrogenesis & Tissue Repair, 3(19)-10. DOI: https://doi.org/10.1186/1755-1536-3-19
Details DOI
-
2010 | Journal Article
Drug-Induced Granulomatous Interstitial Nephritis in a Patient With Ankylosing Spondylitis During Therapy With Adalimumab
Korsten, P. ; Sweiss, N. J.; Nagorsnik, U.; Niewold, T. B.; Groene, H.-J.; Gross, O. & Mueller, G. A. (2010)
American Journal of Kidney Diseases, 56(6) pp. E17-E21. DOI: https://doi.org/10.1053/j.ajkd.2010.08.019
Details DOI PMID PMC WoS
-
2010 | Journal Article
Mycophenolic Acid Predose Concentrations and Renal Function in a Mouse Model for Progressive Renal Fibrosis
Brandhorst, G.; Brehmer, F.; Petrova, D. T; Gross, O.; Miosge, N.; Armstrong, V. W & Oellerich, M. (2010)
Therapeutic Drug Monitoring, 32(1) pp. 73-78. DOI: https://doi.org/10.1097/FTD.0b013e3181c91fc4
Details DOI PMID PMC WoS
-
2010 | Journal Article
Loss of collagen-receptor DDR1 delays renal fibrosis in hereditary type IV collagen disease
Gross, O.; Girgert, R.; Beirowski, B.; Kretzler, M.; Kang, H. G.; Kruegel, J. & Miosge, N. et al. (2010)
Matrix Biology, 29(5) pp. 346-356. DOI: https://doi.org/10.1016/j.matbio.2010.03.002
Details DOI PMID PMC WoS
-
2010 | Journal Article
Interstitial inflammation in Alport syndrome
Jedlicka, J.; Soleiman, A.; Draganovici, D.; Mandelbaum, J.; Ziegler, U.; Regele, H. & Wuethrich, R. P. et al. (2010)
Human Pathology, 41(4) pp. 582-593. DOI: https://doi.org/10.1016/j.humpath.2009.08.024
Details DOI PMID PMC WoS
-
2010 | Journal Article
Mycophenolic Acid Displays IMPDH-Dependent and IMPDH-Independent Effects on Renal Fibroblast Proliferation and Function
Petrova, D. T.; Brandhorst, G.; Brehmer, F. ; Gross, O.; Oellerich, M. & Armstrong, V. W. (2010)
Therapeutic Drug Monitoring, 32(4) pp. 405-412. DOI: https://doi.org/10.1097/FTD.0b013e3181e44260
Details DOI PMID PMC WoS
-
2011 | Conference Abstract
Early therapy improves life expectancy in chronic renal failure: Data from the European ERA-EDTA dialysis registries and the European Alport therapy Register
Temme, J.; Kramer, A.; Peters, F.; Mueller, G.; Lange, K. & Gross, O. (2011)
Der Internist, 52(6) pp. 731-732.
New york: Springer.
Details WoS
-
2011 | Journal Article |
Differential Kidney Proteome Profiling in a Murine Model of Renal Fibrosis under Treatment with Mycophenolate Mofetil
Petrova, D. T.; Brehmer, F.; Schultze, F. C.; Asif, A. R.; Gross, O.; Oellerich, M. & Brandhorst, G. (2011)
Pathobiology, 78(3) pp. 162-170. DOI: https://doi.org/10.1159/000324597
Details DOI PMID PMC WoS
-
2011 | Journal Article
Bacterial CpG-DNA accelerates Alport glomerulosclerosis by inducing an M1 macrophage phenotype and tumor necrosis factor-alpha-mediated podocyte loss
Ryu, M. I.; Kulkarni, O.; Radomska, E.; Miosge, N.; Gross, O. & Anders, H.-J. (2011)
Kidney International, 79(2) pp. 189-198. DOI: https://doi.org/10.1038/ki.2010.373
Details DOI PMID PMC WoS
-
2012 | Conference Abstract
EVALUATION OF EARLY DIAGNOSTIC MARKERS FOR ALPORT SYNDROME BEFORE THE ONSET OF MICROALBUMINURIA IN THE COL4A3-KNOCKOUT ANIMAL MODEL OF CHRONIC PROGRESSIVE RENAL FIBROSIS
Gross, O.; Diana, R.; Gry, D. H.; Asimal, B.; Johanna, T.; Imke, S.-E. & Lydia, W. et al. (2012)
Nephrology Dialysis Transplantation, 27 49th Congress of the European-Renal-Association/European-Dialysis-and-Transplant-Association (ERA-EDTA), Paris, FRANCE.
Oxford: Oxford Univ Press.
Details WoS
-
2012 | Journal Article |
Safety and Efficacy of the ACE-Inhibitor Ramipril in Alport Syndrome: The Double-Blind, Randomized, Placebo-Controlled, Multicenter Phase III EARLY PRO-TECT Alport Trial in Pediatric Patients
Gross, O.; Friede, T.; Hilgers, R.; Görlitz, A.; Gavénis, K.; Ahmed, R. & Dürr, U. (2012)
ISRN Pediatrics, 2012 pp. 1-6. DOI: https://doi.org/10.5402/2012/436046
Details DOI PMID PMC
-
2012 | Journal Article |
Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport Syndrome Research Collaborative
Kashtan, C.; Ding, J.; Gregory, M.; Gross, O.; Heidet, L.; Knebelmann, B. & Rheault, M. et al. (2012)
Pediatric Nephrology, 28(1) pp. 5-11. DOI: https://doi.org/10.1007/s00467-012-2138-4
Details DOI